Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学mRNA/Peptide Cancer Vaccines

Sebastian Kreiter

PhD

🏢BioNTech🌐Germany

Vice President of RNA Cancer Vaccines

42
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Sebastian Kreiter has been instrumental in the design and optimization of BioNTech's mRNA cancer vaccine constructs, engineering poly-neoantigen mRNA cassettes that encode multiple patient-specific neoantigens within a single mRNA molecule for efficient delivery and immune stimulation. His work on optimizing mRNA sequence elements including UTRs, codon usage, and cap structures has maximized the translational efficiency and immunogenicity of cancer vaccine mRNAs. He has contributed to the lipid nanoparticle formulation strategies that enable targeted delivery of mRNA vaccines to antigen-presenting cells.

Share:

🧪Research Fields 研究领域

mRNA vaccine design optimization
Neoantigen mRNA construct engineering
Lipid nanoparticle formulation
Poly-neoantigen mRNA cassettes
Cancer vaccine preclinical development

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Sebastian Kreiter 的研究动态

Follow Sebastian Kreiter's research updates

留下邮箱,当我们发布与 Sebastian Kreiter(BioNTech)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment